CYTOKINETICS INC CYTK
CYTOKINETICS INC statistics & valuation
Market cap$10.2B
Net margin-891.6%
FCF margin-607.5%
Net debt$123.9M
Enterprise value USD$10.4B
Earnings yield EBIT/EV-5.9%
Return on capital-50.1%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -695.4% | -2902.7% | -6589.7% | -342.8% | -264.5% | -168.3% | -368.0% | -282.3% | -848.3% | 17.6% |
| Net margin | -891.6% | -3191.1% | -6988.6% | -411.2% | -305.7% | -228.0% | -452.9% | -337.4% | -955.9% | 15.5% |
| FCF margin | -607.5% | -2164.1% | -5521.2% | -328.6% | -271.8% | -3.8% | -348.1% | -324.1% | -782.7% | 33.3% |
| Return on assets | -55.1% | -42.1% | -63.8% | -38.3% | -25.6% | -23.8% | -42.0% | -50.3% | -43.3% | 9.7% |
| Return on equity | 119.0% | 435.5% | 136.2% | 360.5% | -88.3% | -112.3% | 1112.7% | -409.8% | -116.3% | 17.4% |
| Debt / equity | -0.37× | -4.58× | -1.65× | -6.02× | 0.19× | 0.41× | -4.12× | 1.64× | 0.29× | 0.32× |
| Current ratio | 4.53 | 6.17 | 6.12 | 9.40 | 7.45 | 15.20 | 8.98 | 9.36 | 8.45 | 4.77 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.